Armistice Capital »

Creative Med Technology Hldg shares owned by Armistice Capital

Quarter-by-quarter ownership of Creative Med Technology Hldg (CELZ) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Creative Med Technology Hldg

Tip: Access up to 7 years of quarterly data

All positions including Creative Med Technology Hldg held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Creative Med Technology Hldg by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $61k 42k 1.45

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Creative Med Technology Hldg

Hudson Bay Capital Management
Frigate Ventures
Armistice Capital
XTX Topco
Geode Capital Management
Vanguard Capital Management
Vanguard Fiduciary Trust
Tower Research Capital
Global Retirement Partners
UBS Group
Morgan Stanley
Barclays
SBI Securities

View all funds holding Creative Med Technology Hldg